  Target identification, one of the steps of drug discovery, aims at
identifying biomolecules whose function should be therapeutically altered in
order to cure the considered pathology. This work proposes an algorithm for in
silico target identification using Boolean network attractors. It assumes that
attractors of dynamical systems, such as Boolean networks, correspond to
phenotypes produced by the modeled biological system. Under this assumption,
and given a Boolean network modeling a pathophysiology, the algorithm
identifies target combinations able to remove attractors associated with
pathological phenotypes. It is tested on a Boolean model of the mammalian cell
cycle bearing a constitutive inactivation of the retinoblastoma protein, as
seen in cancers, and its applications are illustrated on a Boolean model of
Fanconi anemia. The results show that the algorithm returns target combinations
able to remove attractors associated with pathological phenotypes and then
succeeds in performing the proposed in silico target identification. However,
as with any in silico evidence, there is a bridge to cross between theory and
practice, thus requiring it to be used in combination with wet lab experiments.
Nevertheless, it is expected that the algorithm is of interest for target
identification, notably by exploiting the inexpensiveness and predictive power
of computational approaches to optimize the efficiency of costly wet lab
experiments.
